サマリー

市場の分析と洞察。血漿由来医薬品の世界市場
COVID-19の流行により、血漿抽出薬の世界市場規模は2022年に百万米ドルと推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に血漿由来医薬品の世界市場の％を占めたアルブミンは、2028年までに100万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国の血漿抽出製剤の市場規模は2021年に百万米ドル、米国と欧州の血漿抽出製剤はそれぞれ百万米ドル、百万米ドルとされています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％であることが判明した。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の血漿抽出医療用医薬品については、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
血漿抽出薬の世界的な主要メーカーは、Grifols、SK Plasma、Fusion Health Care、Biotest AG、GC Pharma、Baxter International、LFB、Octapharma AGおよびCSL Limitedなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の血漿抽出製剤の範囲とセグメント
血漿由来医薬品市場は、タイプ別と用途別に分類されます。世界の血漿由来医薬品市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

タイプ別セグメント
アルブミン
凝固因子
免疫グロブリン
その他
用途別セグメント
病院
クリニック
その他
会社別
グリフォルス
SKプラズマ
フュージョンヘルスケア
ビオテストAG
GCファーマ
バクスター・インターナショナル
LFB
オクタファーマAG
CSLリミテッド
BPL
中国生物学製品
ケドリオン・バイオファーマ
RAAS
天壇バイオ
花蘭生物工学
BOYAバイオ製薬
地域別
北米
米国
カナダ
メキシコ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
ブラジル
中東・アフリカ
トルコ
GCC諸国
エジプト
南アフリカ

ページTOPに戻る

目次

1 Study Coverage
1.1 Plasma Derived Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Derived Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Albumin
1.2.3 Coagulation Factor
1.2.4 Immunoglobulin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Derived Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma Derived Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Plasma Derived Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Plasma Derived Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Plasma Derived Medicine Sales by Region
2.4.1 Global Plasma Derived Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Plasma Derived Medicine by Region (2023-2028)
2.5 Global Plasma Derived Medicine Revenue by Region
2.5.1 Global Plasma Derived Medicine Revenue by Region (2017-2022)
2.5.2 Global Plasma Derived Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Plasma Derived Medicine Sales by Manufacturers
3.1.1 Global Top Plasma Derived Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Derived Medicine in 2021
3.2 Global Plasma Derived Medicine Revenue by Manufacturers
3.2.1 Global Plasma Derived Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2021
3.3 Global Plasma Derived Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plasma Derived Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Derived Medicine Sales by Type
4.1.1 Global Plasma Derived Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Plasma Derived Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Plasma Derived Medicine Sales Market Share by Type (2017-2028)
4.2 Global Plasma Derived Medicine Revenue by Type
4.2.1 Global Plasma Derived Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Plasma Derived Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Plasma Derived Medicine Price by Type
4.3.1 Global Plasma Derived Medicine Price by Type (2017-2022)
4.3.2 Global Plasma Derived Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Plasma Derived Medicine Sales by Application
5.1.1 Global Plasma Derived Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Plasma Derived Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Plasma Derived Medicine Sales Market Share by Application (2017-2028)
5.2 Global Plasma Derived Medicine Revenue by Application
5.2.1 Global Plasma Derived Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Plasma Derived Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Plasma Derived Medicine Price by Application
5.3.1 Global Plasma Derived Medicine Price by Application (2017-2022)
5.3.2 Global Plasma Derived Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Plasma Derived Medicine Market Size by Type
6.1.1 North America Plasma Derived Medicine Sales by Type (2017-2028)
6.1.2 North America Plasma Derived Medicine Revenue by Type (2017-2028)
6.2 North America Plasma Derived Medicine Market Size by Application
6.2.1 North America Plasma Derived Medicine Sales by Application (2017-2028)
6.2.2 North America Plasma Derived Medicine Revenue by Application (2017-2028)
6.3 North America Plasma Derived Medicine Market Size by Country
6.3.1 North America Plasma Derived Medicine Sales by Country (2017-2028)
6.3.2 North America Plasma Derived Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Plasma Derived Medicine Market Size by Type
7.1.1 Europe Plasma Derived Medicine Sales by Type (2017-2028)
7.1.2 Europe Plasma Derived Medicine Revenue by Type (2017-2028)
7.2 Europe Plasma Derived Medicine Market Size by Application
7.2.1 Europe Plasma Derived Medicine Sales by Application (2017-2028)
7.2.2 Europe Plasma Derived Medicine Revenue by Application (2017-2028)
7.3 Europe Plasma Derived Medicine Market Size by Country
7.3.1 Europe Plasma Derived Medicine Sales by Country (2017-2028)
7.3.2 Europe Plasma Derived Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma Derived Medicine Market Size by Type
8.1.1 Asia Pacific Plasma Derived Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Plasma Derived Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Plasma Derived Medicine Market Size by Application
8.2.1 Asia Pacific Plasma Derived Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Plasma Derived Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Plasma Derived Medicine Market Size by Region
8.3.1 Asia Pacific Plasma Derived Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Plasma Derived Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
8.3.12 Vietnam
9 Latin America
9.1 Latin America Plasma Derived Medicine Market Size by Type
9.1.1 Latin America Plasma Derived Medicine Sales by Type (2017-2028)
9.1.2 Latin America Plasma Derived Medicine Revenue by Type (2017-2028)
9.2 Latin America Plasma Derived Medicine Market Size by Application
9.2.1 Latin America Plasma Derived Medicine Sales by Application (2017-2028)
9.2.2 Latin America Plasma Derived Medicine Revenue by Application (2017-2028)
9.3 Latin America Plasma Derived Medicine Market Size by Country
9.3.1 Latin America Plasma Derived Medicine Sales by Country (2017-2028)
9.3.2 Latin America Plasma Derived Medicine Revenue by Country (2017-2028)
9.3.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Plasma Derived Medicine Market Size by Type
10.1.1 Middle East and Africa Plasma Derived Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Plasma Derived Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Plasma Derived Medicine Market Size by Application
10.2.1 Middle East and Africa Plasma Derived Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Plasma Derived Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Plasma Derived Medicine Market Size by Country
10.3.1 Middle East and Africa Plasma Derived Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Plasma Derived Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 GCC Countries
10.3.6 South Africa
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 SK Plasma
11.2.1 SK Plasma Corporation Information
11.2.2 SK Plasma Overview
11.2.3 SK Plasma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 SK Plasma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SK Plasma Recent Developments
11.3 Fusion Health Care
11.3.1 Fusion Health Care Corporation Information
11.3.2 Fusion Health Care Overview
11.3.3 Fusion Health Care Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fusion Health Care Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fusion Health Care Recent Developments
11.4 Biotest AG
11.4.1 Biotest AG Corporation Information
11.4.2 Biotest AG Overview
11.4.3 Biotest AG Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biotest AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biotest AG Recent Developments
11.5 GC Pharma
11.5.1 GC Pharma Corporation Information
11.5.2 GC Pharma Overview
11.5.3 GC Pharma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GC Pharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GC Pharma Recent Developments
11.6 Baxter International
11.6.1 Baxter International Corporation Information
11.6.2 Baxter International Overview
11.6.3 Baxter International Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter International Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter International Recent Developments
11.7 LFB
11.7.1 LFB Corporation Information
11.7.2 LFB Overview
11.7.3 LFB Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 LFB Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 LFB Recent Developments
11.8 Octapharma AG
11.8.1 Octapharma AG Corporation Information
11.8.2 Octapharma AG Overview
11.8.3 Octapharma AG Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Octapharma AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Octapharma AG Recent Developments
11.9 CSL Limited
11.9.1 CSL Limited Corporation Information
11.9.2 CSL Limited Overview
11.9.3 CSL Limited Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSL Limited Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSL Limited Recent Developments
11.10 BPL
11.10.1 BPL Corporation Information
11.10.2 BPL Overview
11.10.3 BPL Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BPL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BPL Recent Developments
11.11 China Biologic Products
11.11.1 China Biologic Products Corporation Information
11.11.2 China Biologic Products Overview
11.11.3 China Biologic Products Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China Biologic Products Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China Biologic Products Recent Developments
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Corporation Information
11.12.2 Kedrion Biopharma Overview
11.12.3 Kedrion Biopharma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kedrion Biopharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kedrion Biopharma Recent Developments
11.13 RAAS
11.13.1 RAAS Corporation Information
11.13.2 RAAS Overview
11.13.3 RAAS Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 RAAS Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RAAS Recent Developments
11.14 Tiantan Bio
11.14.1 Tiantan Bio Corporation Information
11.14.2 Tiantan Bio Overview
11.14.3 Tiantan Bio Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tiantan Bio Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tiantan Bio Recent Developments
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Corporation Information
11.15.2 Hualan Biological Engineering Overview
11.15.3 Hualan Biological Engineering Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Hualan Biological Engineering Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hualan Biological Engineering Recent Developments
11.16 BOYA Bio-Pharmaceutical
11.16.1 BOYA Bio-Pharmaceutical Corporation Information
11.16.2 BOYA Bio-Pharmaceutical Overview
11.16.3 BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 BOYA Bio-Pharmaceutical Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 BOYA Bio-Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Derived Medicine Industry Chain Analysis
12.2 Plasma Derived Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Derived Medicine Production Mode & Process
12.4 Plasma Derived Medicine Sales and Marketing
12.4.1 Plasma Derived Medicine Sales Channels
12.4.2 Plasma Derived Medicine Distributors
12.5 Plasma Derived Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plasma Derived Medicine Industry Trends
13.2 Plasma Derived Medicine Market Drivers
13.3 Plasma Derived Medicine Market Challenges
13.4 Plasma Derived Medicine Market Restraints
14 Key Findings in The Global Plasma Derived Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer